Comparative efficacy and safety of warfarin and direct oral anticoagulants in patients with end-stage kidney disease and atrial fibrillation

Yujin Yang; Sun Hwa Lee; Wonmook Hwang; Ji Hoon Jung; Jae-Hyeong Park

doi:10.3904/kjim.2025.052.e1

Korean J Intern Med > Volume 41(5); 2026 > Article

Yang, Lee, Hwang, Jung, and Park: Comparative efficacy and safety of warfarin and direct oral anticoagulants in patients with end-stage kidney disease and atrial fibrillation

Corrigendum

The Korean Journal of Internal Medicine 2026;41(5):965.

Published online: September 1, 2026

DOI: https://doi.org/10.3904/kjim.2025.052.e1

Comparative efficacy and safety of warfarin and direct oral anticoagulants in patients with end-stage kidney disease and atrial fibrillation

Yujin Yang¹, Sun Hwa Lee², Wonmook Hwang³, Ji Hoon Jung⁴, Jae-Hyeong Park¹

¹Department of Cardiology in Internal Medicine, Chungnam National University Hospital, Chungnam National University College of Medicine, Daejeon, Korea

²Division of Cardiology, Department of Internal Medicine, Jeonbuk National University Medical School and Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, Korea

³Department of Cardiology in Internal Medicine, Chungnam National University Sejong Hospital, Sejong, Korea

⁴Division of Statistics, Office of Information Security, Korea Institute of Toxicology, Daejeon, Korea

(open-access):

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

This corrects the article "Comparative efficacy and safety of warfarin and direct oral anticoagulants in patients with end-stage kidney disease and atrial fibrillation" in volume 41 on page 107.

Korean J Intern Med 2026;41:107–117

https://doi.org/10.3904/kjim.2025.052

The graphical abstract has been revised to more accurately represent the study population and to improve the clarity and consistency of the presentation of the study methods and findings. The original graphical abstract will be replaced with the revised version shown below.

TOOLS

METRICS

0 Crossref
0 Scopus
920 View
32 Download

Related articles

Comparative efficacy and safety of warfarin and direct oral anticoagulants in patients with end-stage kidney disease and atrial fibrillation2026 January;41(1)

Role of catheter ablation in patients with heart failure and atrial fibrillation2025 July;40(4)

Efficacy and safety of denosumab treatment for Korean patients with Stage 3b–4 chronic kidney disease and osteoporosis2024 January;39(1)

Comparative study of the efficacy and safety of Abexol (suspension versus tablets) in patients with gastrointestinal symptoms2024 January;39(1)

Low-dose non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation2023 September;38(5)

Editorial Office: 101-2501, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-2271-6792 Fax: +82-2-790-0993 E-mail: kaim@kams.or.kr